BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36598462)

  • 21. Neuroendoscopic approach to tectal tumors: a consecutive series.
    Oka K; Kin Y; Go Y; Ueno Y; Hirakawa K; Tomonaga M; Inoue T; Yoshioka S
    J Neurosurg; 1999 Dec; 91(6):964-70. PubMed ID: 10584842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tectal Plate Gliomas Masquerading as Idiopathic Aqueduct Stenosis.
    Afshari FT; English M; Lo WB
    World Neurosurg; 2022 Sep; 165():92-94. PubMed ID: 35752420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
    Jaspan T; Morgan PS; Warmuth-Metz M; Sanchez Aliaga E; Warren D; Calmon R; Grill J; Hargrave D; Garcia J; Zahlmann G
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1581-7. PubMed ID: 27127006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
    Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
    World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI.
    Gamboa NT; Crabb B; Henson JC; Cole KL; Weaver BD; Karsy M; Jensen RL
    J Neurooncol; 2022 Dec; 160(3):555-565. PubMed ID: 36394718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tectal plate lesions in children.
    Ternier J; Wray A; Puget S; Bodaert N; Zerah M; Sainte-Rose C
    J Neurosurg; 2006 Jun; 104(6 Suppl):369-76. PubMed ID: 16776370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping.
    Motomura K; Chalise L; Ohka F; Aoki K; Tanahashi K; Hirano M; Nishikawa T; Yamaguchi J; Shimizu H; Wakabayashi T; Saito R
    J Neurooncol; 2021 Jun; 153(2):361-372. PubMed ID: 34009509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Edge Contrast of the FLAIR Hyperintense Region Predicts Survival in Patients with High-Grade Gliomas following Treatment with Bevacizumab.
    Bahrami N; Piccioni D; Karunamuni R; Chang YH; White N; Delfanti R; Seibert TM; Hattangadi-Gluth JA; Dale A; Farid N; McDonald CR
    AJNR Am J Neuroradiol; 2018 Jun; 39(6):1017-1024. PubMed ID: 29622553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
    Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
    Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter.
    Ramnarayan R; Dodd S; Das K; Heidecke V; Rainov NG
    J Neurol Sci; 2007 Sep; 260(1-2):49-56. PubMed ID: 17475281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tectal plate gliomas. Part I: Microsurgery of the tectal plate gliomas.
    Lapras C; Bognar L; Turjman F; Villanyi E; Mottolese C; Fischer C; Jouvet A; Guyotat J
    Acta Neurochir (Wien); 1994; 126(2-4):76-83. PubMed ID: 8042559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Law M; Young RJ; Babb JS; Peccerelli N; Chheang S; Gruber ML; Miller DC; Golfinos JG; Zagzag D; Johnson G
    Radiology; 2008 May; 247(2):490-8. PubMed ID: 18349315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Multi-Institutional Analysis of Factors Influencing Surgical Outcomes for Patients with Newly Diagnosed Grade I Gliomas.
    Yahanda AT; Patel B; Sutherland G; Honeycutt J; Jensen RL; Smyth MD; Limbrick DD; Dacey RG; Dowling JL; Dunn GP; Kim AH; Leuthardt EC; Rich KM; Zipfel GJ; Leonard JR; Cahill DP; Shah MV; Abram SR; Evans J; Tao Y; Chicoine MR
    World Neurosurg; 2020 Mar; 135():e754-e764. PubMed ID: 31901497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes.
    Brendle C; Klose U; Hempel JM; Schittenhelm J; Skardelly M; Tabatabai G; Ernemann U; Bender B
    Neurol Sci; 2020 Dec; 41(12):3625-3632. PubMed ID: 32462389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial impact of high-field intraoperative magnetic resonance imaging on the efficacy of pediatric low-grade glioma surgery.
    Roder C; Breitkopf M; Ms ; Bisdas S; Freitas Rda S; Dimostheni A; Ebinger M; Wolff M; Tatagiba M; Schuhmann MU
    Neurosurg Focus; 2016 Mar; 40(3):E13. PubMed ID: 26926053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure.
    Vöglein J; Tüttenberg J; Weimer M; Gerigk L; Kauczor HU; Essig M; Weber MA
    Invest Radiol; 2011 Jun; 46(6):390-400. PubMed ID: 21285888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Globular glioma of the tectum.
    Antunes NL; Tavora L; Souweidane M
    Pediatr Neurol; 1999 Jul; 21(1):492-5. PubMed ID: 10428437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benign intrinsic tectal "tumors" in children.
    May PL; Blaser SI; Hoffman HJ; Humphreys RP; Harwood-Nash DC
    J Neurosurg; 1991 Jun; 74(6):867-71. PubMed ID: 2033445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.
    Wang YY; Wang K; Li SW; Wang JF; Ma J; Jiang T; Dai JP
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2023-9. PubMed ID: 26316565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.